Impulsivity, hyperactivity, and difficulty concentrating are some of the symptoms associated with attention deficit ...
Virginia Tech has launched a pilot study investigating whether learning to DJ can help young adults manage symptoms of ...
For years, people thought that attention deficit hyperactivity disorder (ADHD) was a problem that only kids had. It was ...
Attention-Deficit Hyperactivity Disorder, or ADHD, affects tens of millions of people in the U.S.About one in nine children ...
The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...
Pharmaceutical Technology on MSN
FDA accepts Otsuka’s centanafadine application for ADHD treatment
The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.
The hyperactivity disorder, usually referred to as ADHD, is an independent risk factor for several common and serious mental health issues, finds research published in the open access journal BMJ ...
Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and ...
More people with attention-deficit/hyperactivity disorder (ADHD) are turning to coaches for guidance. Those coaches, who ...
UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it ...
The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder (ADHD), centanafadine, setting up a decision by 24th July.
Hilton was diagnosed with ADHD as an adult, and although she struggled to cope with some of the symptoms as a teen, she now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results